News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
3,539 Results
Type
Article (238)
Press Release (3301)
Section
Business (1067)
Career Advice (8)
Deals (260)
Drug Development (623)
FDA (80)
Job Trends (76)
News (1760)
Policy (132)
Tag
Academia (12)
Accelerated approval (1)
Adcomms (1)
Allergies (1)
Alliances (132)
ALS (1)
Alzheimer's disease (3)
Antibody-drug conjugate (ADC) (11)
Approvals (93)
Artificial intelligence (4)
ASCO (12)
Autoimmune disease (6)
Bankruptcy (3)
Best Places to Work (77)
BIO (2)
Biologics (2)
Biosimilars (29)
Bispecific (5)
Brain cancer (1)
Breast cancer (45)
Cancer (156)
Cardiovascular disease (17)
Career advice (7)
CAR-T (5)
CDC (1)
CDMO (1)
Cell therapy (23)
Clinical research (626)
Collaboration (16)
Compensation (5)
Complete response letters (1)
COVID-19 (4)
CRISPR (1)
C-suite (12)
Cystic fibrosis (1)
Data (155)
Dermatology (1)
Diabetes (8)
Diagnostics (28)
Digital health (1)
Drug discovery (3)
Drug pricing (1)
Duchenne muscular dystrophy (2)
Earnings (803)
ESMO (13)
Events (443)
Executive appointments (8)
FDA (141)
Funding (20)
Gene editing (1)
Gene therapy (7)
GLP-1 (12)
Government (10)
Guidances (14)
Healthcare (133)
Hematology (5)
IgA nephropathy (1)
Immunology and inflammation (6)
Immuno-oncology (3)
Indications (3)
Infectious disease (5)
Inflammatory bowel disease (2)
Intellectual property (3)
Interviews (3)
IPO (106)
Job creations (2)
Job search strategy (3)
Layoffs (3)
Legal (13)
Liver cancer (2)
Lung cancer (21)
Lymphoma (13)
Machine learning (1)
Manufacturing (6)
Medical device (55)
Medtech (57)
Melanoma (1)
Mergers & acquisitions (193)
Metabolic disorders (17)
mRNA (1)
Multiple sclerosis (2)
Neurodegenerative disease (1)
Neuroscience (9)
NextGen: Class of 2026 (33)
Non-profit (4)
Obesity (8)
Ovarian cancer (2)
Pain (1)
Pancreatic cancer (4)
Patents (7)
Patient recruitment (9)
Peanut (1)
People (152)
Phase 1 (175)
Phase 2 (217)
Phase 3 (291)
Pipeline (207)
Policy (1)
Postmarket research (14)
Preclinical (74)
Prostate cancer (7)
Radiopharmaceuticals (1)
Rare diseases (7)
Real estate (2)
Regulatory (198)
Research institute (13)
Resumes & cover letters (2)
Series A (4)
Series B (5)
Startups (6)
Stem cells (1)
Stomach cancer (2)
Supply chain (1)
Vaccines (6)
Weight loss (2)
Women's health (9)
Date
Last 7 days (8)
Last 30 days (46)
Last 365 days (345)
2026 (313)
2025 (342)
2024 (343)
2023 (351)
2022 (351)
2021 (299)
2020 (191)
2019 (167)
2018 (139)
2017 (118)
2016 (105)
2015 (106)
2014 (109)
2013 (74)
2012 (81)
2011 (65)
2010 (84)
Location
Africa (2)
Alabama (1)
Asia (198)
Australia (25)
California (244)
Canada (8)
China (32)
Colorado (11)
Connecticut (2)
Delaware (11)
Europe (598)
Florida (36)
Georgia (2)
Idaho (1)
Illinois (22)
Indiana (10)
Japan (5)
Kansas (1)
Kentucky (1)
Maine (1)
Maryland (11)
Massachusetts (93)
Michigan (1)
Minnesota (5)
New Jersey (48)
New York (30)
North Carolina (15)
Northern California (208)
Ohio (10)
Pennsylvania (8)
South America (2)
Southern California (23)
Texas (55)
United States (611)
Utah (1)
Washington D.C. (2)
Washington State (14)
Wisconsin (6)
3,539 Results for "immatics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Immatics Announces Third Quarter 2026 Financial Results and Business Update
November 10, 2026
·
18 min read
Press Releases
Immatics Announces $150 Million Underwritten Offering
August 25, 2026
·
3 min read
Press Releases
Immatics Announces Second Quarter 2026 Financial Results and Business Update
August 18, 2026
·
20 min read
Press Releases
Immatics Announces Upcoming Presentations Across Its PRAME Franchise at ESMO Congress 2026
July 19, 2026
·
5 min read
Press Releases
Immatics Presents Clinical Activity of IMA402 PRAME Bispecific and IMA203CD8 PRAME Cell Therapy across Advanced Solid Tumors in Two Oral Presentations at 2026 ESMO Annual Meeting
October 26, 2026
·
14 min read
Press Releases
Immatics Announces First Quarter 2026 Financial Results and Business Update
May 12, 2026
·
18 min read
Press Releases
Immatics Presents Clinical Activity and Response Dynamics of Anzu-cel PRAME Cell Therapy at 2026 ASCO Annual Meeting
June 1, 2026
·
9 min read
Press Releases
Immatics Announces Full Year 2025 Financial Results and Business Update
March 5, 2026
·
20 min read
Press Releases
Immatics Announces $125 Million Underwritten Offering
December 5, 2025
·
3 min read
Press Releases
Immatics Presents Clinical Activity of IMA203CD8 PRAME Cell Therapy in Hard-to-Treat Gynecologic Cancers at 2026 ASCO Annual Meeting
June 1, 2026
·
10 min read
1 of 354
Next